Transplantation Tolerance-where Do We Stand?

Overview

Journal Nat Med

Specialties General Medicine
Molecular Biology

Date 1999 Nov 5

PMID 10545989

Citations 12

Authors

H Waldmann

Affiliations

Soon will be listed here.

Abstract

Our understanding of tolerance mechanisms has progressed to the point that tolerance-induction protocols are being tested in humans for organ transplantation. However, a range of scientific, ethical, logistic and commercial issues have arisen, and must be resolved before tolerance induction for human allograft patients can become a reality.

Citing Articles

Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells.

Abomaray F, Al Jumah M, Kalionis B, Alaskar A, Al Harthy S, Jawdat D Stem Cell Rev Rep. 2014; 11(3):423-41.

PMID: 25287760 DOI: 10.1007/s12015-014-9562-8.

Vascularized composite allograft rejection is delayed by intrajejunal treatment with donor splenocytes without concomitant immunosuppressants.

Wallace C, Yen C, Yang H, Lin C, Wu R, Huang W Clin Dev Immunol. 2012; 2012:704063.

PMID: 23227087 PMC: 3514848. DOI: 10.1155/2012/704063.

Enhancing clinical islet transplantation through tissue engineering strategies.

Giraldo J, Weaver J, Stabler C J Diabetes Sci Technol. 2010; 4(5):1238-47.

PMID: 20920446 PMC: 2956806. DOI: 10.1177/193229681000400525.

An update on regulatory T cells in transplant tolerance and rejection.

Li X, Turka L Nat Rev Nephrol. 2010; 6(10):577-83.

PMID: 20683480 DOI: 10.1038/nrneph.2010.101.

STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants.

Stojanovic T, Wagner A, Wang S, Kiss E, Rockstroh N, Bedke J Basic Res Cardiol. 2009; 104(6):719-29.

PMID: 19352584 PMC: 3085763. DOI: 10.1007/s00395-009-0028-0.